Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Investigators discover clues to the functions of apoE

May 22, 1998

Selective dopamine D3 receptor ligands developed at Neurogen

May 22, 1998

Fiblast North American stroke trial suspended

May 21, 1998

IRFI-165, an adenosine antagonist for the treatment of depression

May 21, 1998

Vanguard Medica and SmithKline Beecham terminate frovatriptan collaboration

May 20, 1998

New treatments for Alzheimer's disease in the pipeline at Schering-Plough

May 20, 1998

Neuroprotective heterocyclic compounds developed at Cambridge NeuroScience

May 19, 1998

Rivastigmine ameliorates immediate and long-term sequelae of closed-head injury

May 19, 1998

Postmarketing evaluation of Clozaril may lead to increased patient availability

May 19, 1998

Scios and Janssen to copromote Risperdal

May 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 17, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...